Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.
about
Loss of Polo ameliorates APP-induced Alzheimer's disease-like symptoms in DrosophilaDrosophila as an In Vivo Model for Human Neurodegenerative DiseaseAlpha-synuclein and tau: teammates in neurodegeneration?α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.What we can learn from animal models about cerebral multi-morbidity.Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.Impaired intracellular trafficking defines early Parkinson's diseaseNeurophysiology of Drosophila models of Parkinson's disease.Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease.αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.A Preliminary Study on Investigation of Serum α-Synuclein and Tau Protein Levels in Children with Attention Deficit Hyperactivity Disorder.Regional Overlap of Pathologies in Lewy Body Disorders.The direct and indirect effects of α-synuclein on microtubule stability in the pathogenesis of Parkinson's disease.Tau Pathology in Parkinson's DiseaseUntangling Tau and Iron: Exploring the Interaction Between Iron and Tau in NeurodegenerationProtein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification
P2860
Q27305748-52532464-150B-4373-B5EF-19E50C887012Q28088777-A699D53B-3E15-42C4-BF42-DF5AEF623095Q28250508-61AE5D06-94F3-460F-ABDE-DD2ADD49FA3DQ35163459-08AF5DEF-FAB4-4D91-BAF8-1545AB7C475DQ35215656-308F1725-7877-4CA3-B559-F59D32A0DFC8Q36484413-C83A261A-71C1-42A9-972A-AEC079B96A38Q37407659-352A288A-4D22-46BA-92EB-31BFA3A41C33Q38256380-93B79AAF-6AC7-4E8A-B821-C2B8352EF693Q38471281-3A1195C2-6ADC-45B3-B7DC-CA19FC4685A7Q38730062-7B5B8505-7D99-4236-83DC-C5E11D444B60Q38954686-43FBAF14-A148-4C1F-BFF0-85CC0FA5F7A2Q39289038-FE6C6ED5-E3A2-407F-81F3-403D2D4F50CEQ40986110-F48440BB-FFDA-4FC5-8F3C-98584CFB07A8Q41985945-D4B48C69-9507-493A-8A5C-EC0AECA19803Q42095746-FFCEE8AD-21FD-4AA5-BE24-4FEFE34595F0Q47296303-B3923432-CE89-46C4-9E9E-990B1A3ABE24Q50211142-28281AE1-D8BD-4C69-B8F6-15055D86BC50Q55511198-E8263492-1640-42D8-A4C8-05713799EF49Q58586744-43E1332A-589D-42B0-93CF-E36D131D9DC6Q58769184-B020A09F-6552-414D-84CE-42D894B67453Q58800414-43350F2E-3C51-4AE5-BFF0-5DFAC6FE9208
P2860
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interactions between Tau and α ...... model of Parkinson's disease.
@ast
Interactions between Tau and α ...... model of Parkinson's disease.
@en
type
label
Interactions between Tau and α ...... model of Parkinson's disease.
@ast
Interactions between Tau and α ...... model of Parkinson's disease.
@en
prefLabel
Interactions between Tau and α ...... model of Parkinson's disease.
@ast
Interactions between Tau and α ...... model of Parkinson's disease.
@en
P2860
P921
P356
P1476
Interactions between Tau and α ...... model of Parkinson's disease.
@en
P2093
Bidisha Roy
George R Jackson
P2860
P304
P356
10.1093/HMG/DDU011
P577
2014-01-14T00:00:00Z